OTCMKTS:APPB

Applied Biosciences Competitors

$0.21
-0.17 (-44.74 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.21
Now: $0.21
$0.21
50-Day Range
$0.01
MA: $0.14
$0.40
52-Week Range
$0.00
Now: $0.21
$0.85
Volume100 shs
Average Volume4,095 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Applied Biosciences (OTCMKTS:APPB) Vs. ABAHF, ACRGF, AYRSF, CANB, CNTMF, and CWBHF

Should you be buying APPB stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Applied Biosciences, including Abacus Health Products (ABAHF), Acreage (ACRGF), Ayr Strategies (AYRSF), Can B (CANB), Cansortium (CNTMF), and Charlotte's Web (CWBHF).

Applied Biosciences (OTCMKTS:APPB) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership.

Profitability

This table compares Applied Biosciences and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Earnings and Valuation

This table compares Applied Biosciences and Abacus Health Products' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and price targets for Applied Biosciences and Abacus Health Products, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Abacus Health Products0000N/A

Applied Biosciences (OTCMKTS:APPB) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations and institutional ownership.

Profitability

This table compares Applied Biosciences and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
AcreageN/AN/AN/A

Valuation & Earnings

This table compares Applied Biosciences and Acreage's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Applied Biosciences and Acreage, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Acreage01202.67

Acreage has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher possible upside, analysts clearly believe Acreage is more favorable than Applied Biosciences.

Summary

Acreage beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Applied Biosciences and Ayr Strategies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Ayr Strategies01602.86

Ayr Strategies has a consensus price target of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher possible upside, analysts clearly believe Ayr Strategies is more favorable than Applied Biosciences.

Profitability

This table compares Applied Biosciences and Ayr Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
Ayr StrategiesN/AN/AN/A

Valuation & Earnings

This table compares Applied Biosciences and Ayr Strategies' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
Ayr StrategiesN/AN/AN/AN/AN/A

Summary

Ayr Strategies beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Applied Biosciences (OTCMKTS:APPB) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Can B and Applied Biosciences, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Can B0000N/A
Applied Biosciences0000N/A

Profitability

This table compares Can B and Applied Biosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Can BN/AN/AN/A
Applied BiosciencesN/AN/AN/A

Earnings and Valuation

This table compares Can B and Applied Biosciences' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Can BN/AN/AN/AN/AN/A
Applied BiosciencesN/AN/AN/AN/AN/A

Cansortium (OTCMKTS:CNTMF) and Applied Biosciences (OTCMKTS:APPB) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares Cansortium and Applied Biosciences' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CansortiumN/AN/AN/AN/AN/A
Applied BiosciencesN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current recommendations and price targets for Cansortium and Applied Biosciences, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cansortium00103.00
Applied Biosciences0000N/A

Cansortium currently has a consensus price target of $1.20, indicating a potential upside of 6.10%. Given Cansortium's higher possible upside, research analysts plainly believe Cansortium is more favorable than Applied Biosciences.

Profitability

This table compares Cansortium and Applied Biosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CansortiumN/AN/AN/A
Applied BiosciencesN/AN/AN/A

Summary

Cansortium beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Charlotte's Web (OTCMKTS:CWBHF) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Profitability

This table compares Applied Biosciences and Charlotte's Web's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
Charlotte's WebN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and price targets for Applied Biosciences and Charlotte's Web, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Charlotte's Web01302.75

Charlotte's Web has a consensus target price of $7.25, indicating a potential upside of 85.76%. Given Charlotte's Web's higher possible upside, analysts plainly believe Charlotte's Web is more favorable than Applied Biosciences.

Earnings & Valuation

This table compares Applied Biosciences and Charlotte's Web's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
Charlotte's WebN/AN/AN/AN/AN/A

Summary

Charlotte's Web beats Applied Biosciences on 2 of the 2 factors compared between the two stocks.


Applied Biosciences Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84-5.4%$0.00N/A0.00News Coverage
Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77-0.0%$0.00N/A0.00
AYRSF
Ayr Strategies
1.4$21.26-0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.52-3.5%$0.00N/A0.00Gap Down
Cansortium logo
CNTMF
Cansortium
0.9$1.13-4.5%$0.00N/A0.00Gap Down
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$3.90-2.8%$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.09-0.0%$0.00N/A0.00Gap Down
CPHRF
Cipher Pharmaceuticals
1.2$1.07-0.9%$0.00N/A0.00
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.20-15.0%$0.00N/A0.00News Coverage
Gap Up
Cosmos logo
COSM
Cosmos
0.5$6.30-8.7%$0.00N/A0.00High Trading Volume
Increase in Short Interest
Gap Down
Cresco Labs logo
CRLBF
Cresco Labs
1.3$11.25-6.5%$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$12.77-2.5%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00-33.3%$0.00N/A0.00Gap Down
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15-1.7%$0.00N/A0.00
EVIO logo
EVIO
EVIO
0.6$0.00-8.7%$0.00N/A0.00Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.19-13.5%$0.00N/A0.00Gap Up
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05-0.0%$0.00N/A0.00Gap Down
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01-11.3%$0.00N/A0.00Gap Down
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$26.82-1.2%$0.00N/A0.00Gap Down
GTEC logo
GGTTF
GTEC
0.6$0.57-7.0%$0.00N/A0.00Gap Up
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.85-0.7%$0.00N/A0.00Gap Up
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01-0.0%$0.00N/A0.00
Hexo logo
HYYDF
Hexo
0.6N/AN/A$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$65.83-5.2%$0.00N/A0.00Gap Down
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.18-6.7%$0.00N/A0.00Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.27-3.7%$0.00N/A0.00Gap Up
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Invictus MD Strategies logo
IVITF
Invictus MD Strategies
0.6$0.04-0.0%$0.00N/A0.00
Isodiol International logo
ISOLF
Isodiol International
0.4$0.06-0.2%$0.00N/A0.00Gap Down
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.38-10.2%$0.00N/A0.00Gap Up
KHTRF
Knight Therapeutics
1.2$4.15-0.7%$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00Gap Down
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05-0.0%$0.00N/A0.00News Coverage
Gap Down
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.37-0.0%$0.00N/A0.00Increase in Short Interest
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.26-7.7%$0.00N/A0.00Gap Down
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$35.05-1.3%$0.00N/A0.00Increase in Short Interest
MJardin Group logo
MJARF
MJardin Group
1.1$0.06-16.8%$0.00N/A0.00Gap Up
MYHI
Mountain High Acquisitions
0.5$0.02-17.0%$0.00N/A0.00Gap Up
PHCEF
Pharmacielo
0.7$1.34-6.7%$0.00N/A0.00Gap Up
Plus Products logo
PLPRF
Plus Products
1.1$0.51-2.0%$0.00N/A0.00Gap Down
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00-4.0%$0.00N/A0.00Gap Up
PCYN
Procyon
0.4$0.60-0.0%$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01-2.8%$0.00N/A0.00
SANP
Santo Mining
0.5$0.00-0.0%$0.00N/A0.00
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$12.76-2.1%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40-0.0%$0.00N/A0.00News Coverage
TerrAscend logo
TRSSF
TerrAscend
1.7$9.95-1.9%$0.00N/A0.00
The Flowr logo
FLWPF
The Flowr
1.5$0.22-2.5%$0.00N/A0.00Gap Up
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.2$0.28-7.2%$0.00N/A0.00
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.